Sangeeta Bhorade to Graft Rejection
This is a "connection" page, showing publications Sangeeta Bhorade has written about Graft Rejection.
Connection Strength
3.387
-
Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation. PLoS One. 2014; 9(7):e103643.
Score: 0.324
-
The lung microbiome after lung transplantation. Expert Rev Respir Med. 2014 Apr; 8(2):221-31.
Score: 0.317
-
Invited commentary. Ann Thorac Surg. 2014 Jan; 97(1):274-5.
Score: 0.311
-
Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013 Jun; 143(6):1717-1724.
Score: 0.299
-
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. J Heart Lung Transplant. 2011 Feb; 30(2):175-81.
Score: 0.249
-
Immunosuppression for lung transplantation. Proc Am Thorac Soc. 2009 Jan 15; 6(1):47-53.
Score: 0.221
-
Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection. Chest. 2007 Feb; 131(2):533-8.
Score: 0.193
-
Evolving immunosuppressive regimens for lung transplant recipients. Semin Respir Crit Care Med. 2006 Oct; 27(5):470-9.
Score: 0.188
-
Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest. 2006 Sep; 130(3):847-54.
Score: 0.187
-
Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. J Heart Lung Transplant. 2005 Apr; 24(4):421-5.
Score: 0.170
-
Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant. 2003 Dec; 3(12):1570-5.
Score: 0.155
-
Clinical relevance of lung-restricted antibodies in lung transplantation. Hum Immunol. 2019 Aug; 80(8):595-601.
Score: 0.113
-
Executive summary: monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):1284-1288.
Score: 0.072
-
Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):e1S-e111S.
Score: 0.072
-
SaLUTaRy: survey of lung transplant rejection. J Heart Lung Transplant. 2012 Sep; 31(9):972-9.
Score: 0.071
-
Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52.
Score: 0.070
-
Conventional and novel approaches to immunosuppression. Clin Chest Med. 2011 Jun; 32(2):265-77.
Score: 0.065
-
Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation. 2010 Sep 15; 90(5):540-6.
Score: 0.062
-
Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med. 2011 Feb 01; 183(3):379-87.
Score: 0.062
-
Current trends in immunosuppression for lung transplantation. Semin Respir Crit Care Med. 2010 Apr; 31(2):172-8.
Score: 0.060
-
Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant. 2002 Dec; 21(12):1274-82.
Score: 0.036
-
Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant. 2000; 5(3):44-7.
Score: 0.029
-
Lung transplantation at Loyola University Medical Center. Clin Transpl. 1999; 281-8.
Score: 0.028
-
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2018 01 15; 197(2):235-243.
Score: 0.026
-
Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation. 2001 Mar 27; 71(6):773-7.
Score: 0.008